Long-acting stimulants for the treatment of attention-deficit disorder in cocaine-dependent adults.
Castaneda
R
R
Department of Psychiatry at Bellevue Hospital, New York University Medical Center, New York, New York, USA. castar01@popmail.med.byu.edu
Levy
R
R
Hardy
M
M
Trujillo
M
M
D000328:Adult; D000465:Algorithms; D000662:Amphetamines / Q000627:therapeutic use; D018687:Antidepressive Agents, Second-Generation / Q000627:therapeutic use*; D001289:Attention Deficit Disorder with Hyperactivity / Q000150:complications / Q000188:drug therapy*; D016642:Bupropion / Q000627:therapeutic use; D000697:Central Nervous System Stimulants / Q000008:administration & dosage / Q000627:therapeutic use*; D019970:Cocaine-Related Disorders / Q000209:etiology*; D003692:Delayed-Action Preparations; D017831:Diagnosis, Dual (Psychiatry); D004359:Drug Therapy, Combination; D005473:Fluoxetine / Q000627:therapeutic use; D006801:Humans; D008774:Methylphenidate / Q000627:therapeutic use; D017063:Outcome Assessment, Health Care; D010389:Pemoline / Q000627:therapeutic use
D000662:Amphetamines; D018687:Antidepressive Agents, Second-Generation; D000697:Central Nervous System Stimulants; D003692:Delayed-Action Preparations; D005473:Fluoxetine; D016642:Bupropion; D008774:Methylphenidate; D010389:Pemoline